Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19067370.
- Also identified by DOI 10.1002/ana.21528 and PMC identifier 2605158.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Imaging of cerebrovascular beta-amyloid (cerebral amyloid angiopathy) is complicated by the nearly universal overlap of this pathology with Alzheimer's pathology. We performed positron emission tomographic imaging with Pittsburgh Compound B on 42-year-old man with early manifestations of Iowa-type hereditary cerebral amyloid angiopathy, a form of the disorder with little or no plaque deposits of fibrillar beta-amyloid. The results demonstrated increased Pittsburgh Compound B retention selectively in occipital cortex, sparing regions typically labeled in Alzheimer's disease. These results offer compelling evidence that Pittsburgh Compound B positron emission tomography can noninvasively detect isolated cerebral amyloid angiopathy before overt signs of tissue damage such as hemorrhage or white matter lesions.
Medical subject headings
- Amyloid beta-Peptides
- Aniline Compounds
- Brain
- Cerebral Amyloid Angiopathy
- Thiazoles